Actively Recruiting

Phase Not Applicable
Age: 18Years - 35Years
FEMALE
NCT07255911

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

Led by Mst.Sumyara Khatun · Updated on 2025-12-16

72

Participants Needed

1

Research Sites

72 weeks

Total Duration

On this page

Sponsors

M

Mst.Sumyara Khatun

Lead Sponsor

B

Bangladesh Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Does combined Cabergoline and letrozole increase ovulation rate What medical problems do participants have when taking drug Cabergoline and Letrozole ? Researchers will compare drug combination of Cabergoline and letrozole to letrozole alone to see combined cabergoline and letrozole works better as ovulation induction. Participants will: experimental group will receive Cabergoline and Letrozole comparator group will receive letrozole alone TVS Monitoring will be done for 3 cycle for ovarian response

CONDITIONS

Official Title

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

Who Can Participate

Age: 18Years - 35Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 to 35 years
  • Diagnosed with polycystic ovary syndrome (PCOS) based on Rotterdam criteria
  • Experiencing primary or secondary subfertility
  • Selected for ovulation induction treatment
Not Eligible

You will not qualify if you...

  • Women with PCOS-like symptoms from other conditions such as late onset congenital adrenal hyperplasia or Cushing syndrome
  • Serum prolactin levels higher than 50 ng/ml
  • Male factor infertility
  • Other infertility causes like endometriosis, pelvic inflammatory disease, uterine or tubal problems
  • Uncontrolled medical diseases including diabetes, hypertension, kidney or liver disease
  • History of allergic reaction to cabergoline or letrozole
  • Thyroid dysfunction with serum TSH 5 mIU/L or higher
  • Body mass index (BMI) below 18.5 or above 30 kg/m2
  • Currently on metformin therapy
  • Taking medications such as domperidone, metoclopramide, haloperidol, risperidone, amitriptyline, clomipramine, verapamil, methyldopa, or reserpine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bangladesh Medical University

Dhaka, Shahbag, Bangladesh, 1000

Actively Recruiting

Loading map...

Research Team

M

Mst.Sumyara Khatun, MS

CONTACT

N

Nespatul Jannat, MBBS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS | DecenTrialz